iTeos Therapeutics, Inc.
ITOS
$7.32
$0.131.81%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.63% | -536.34% | 81.35% | -25.09% | 5.24% |
| Total Depreciation and Amortization | 6.62% | -2.58% | 1.97% | 33.92% | 1.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -91.99% | 15.14% | 16.56% | -9.69% | 13.92% |
| Change in Net Operating Assets | 2,858.50% | 105.05% | -3,370.71% | -91.43% | 284.27% |
| Cash from Operations | 114.72% | -10.09% | -4.71% | -135.38% | 59.38% |
| Capital Expenditure | -61.70% | 78.73% | 53.23% | 32.31% | -85.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 115.07% | -645.19% | 124.42% | -209.06% | 168.52% |
| Cash from Investing | 114.88% | -660.53% | 123.45% | -213.07% | 171.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 495.65% | -99.96% | 556,154.55% | -92.83% | 2,970.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 102.25% | -- | -- | -- | -- |
| Cash from Financing | 164.48% | -100.36% | 556,154.55% | -92.83% | 2,970.00% |
| Foreign Exchange rate Adjustments | -152.82% | 769.55% | 88.68% | -143.70% | -17.09% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 114.43% | -221.89% | 199.95% | -322.17% | 489.42% |
